Mechanisms of disease - Chronic myeloid leukemia - Advances in biology and new approaches to treatment

被引：679
作者：
Goldman, JM [1 ]
Melo, JV [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Haematol, London SW7 2AZ, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 349卷 / 15期
关键词：
D O I：
10.1056/NEJMra020777
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1451 / 1464
页数：14
相关论文
共 137 条
  • [1] Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL
    Azam, M
    Latek, RR
    Daley, GQ
    [J]. CELL, 2003, 112 (06) : 831 - 843
  • [2] A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemia
    Baccarani, M
    Rosti, G
    de Vivo, A
    Bonifazi, F
    Russo, D
    Martinelli, G
    Testoni, N
    Amabile, M
    Fiacchini, M
    Montefusco, E
    Saglio, G
    Tura, S
    [J]. BLOOD, 2002, 99 (05) : 1527 - 1535
  • [3] Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia
    Barnes, DJ
    Melo, JV
    [J]. ACTA HAEMATOLOGICA, 2002, 108 (04) : 180 - 202
  • [4] Graft-versus-leukaemia: Understanding and using the alloimmune response to treat haematological malignancies
    Barrett, AJ
    Malkovska, V
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) : 754 - 761
  • [5] Allogeneic stem cell transplantation for chronic myeloid leukemia
    Barrett, J
    [J]. SEMINARS IN HEMATOLOGY, 2003, 40 (01) : 59 - 71
  • [6] BEDI A, 1994, BLOOD, V83, P2038
  • [7] Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells
    Bhat, A
    Kolibaba, K
    Oda, T
    OhnoJones, S
    Heaney, C
    Druker, BJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) : 16170 - 16175
  • [8] BIERNAUX C, 1995, BLOOD, V86, P3118
  • [9] The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease
    Bose, S
    Deininger, M
    Gora-Tybor, J
    Goldman, JM
    Melo, JV
    [J]. BLOOD, 1998, 92 (09) : 3362 - 3367
  • [10] High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance
    Branford, S
    Rudzki, Z
    Walsh, S
    Grigg, A
    Arthur, C
    Taylor, K
    Herrmann, R
    Lynch, KP
    Hughes, TP
    [J]. BLOOD, 2002, 99 (09) : 3472 - 3475
12345678910